Choroid plexus has a major role in regulating the composition of brain extracellular fluid. Recently, growth- factors have been identified in choroid plexus, an epithelium well known for its secretory function. Because peptides like fibroblast growth factor (FGF)-2 and transforming growth factor(TGF)- 1 have key roles in CNS ontogeny, and in the response to brain injury, there is the intriguing possibility that choroid plexus secretes growth factors into cerebrospinal fluid (CSF) for bulk flow distribution to target cells the developing or traumatized brain. There is a need to elucidate factors that regulate the composition of FGF-2 and TGF-B1 (and other isoforms) in CSF. We hypothesize that levels of these growth factors in CSF promote brain development, and repair after injury. However, deficient or excessive levels of FGF-2 and TGF- Betal may occur in aging or hydrocephalus, respectively. It seems reasonable to postulate that substantial alterations in CSF growth factor concentrations can markedly alter CSF dynamics, and thus brain function. Three models of Sprague-Dawley rats will be used: I) age progression (infant, young adult and aged animals), 2) hydrocephalus, and 3) transient forebrain ischemia (bilateral carotid occlusion). Our preliminary data indicate that infusion of an endogenous substance, i.e., FGF-2, into a lateral ventricle results in hydrocephalus. Overall, our strategy will be to infuse FGF-2 and TGF-p 1, with or without agents that interfere with the ability of these growth factors to act on their respective receptors. Responses to treatments will be characterized at levels of: a) expression of FGF-2 and TGF-Beta1 proteins and their receptors, b) ultrastructure of the cells surrounding CSF (choroid, ependyma, and arachnoid villi), and c) function (i.e., choroid plexus blood flow, ion transport and CSF secretion). The long-term goal is to gain an enhanced understanding of the role of FGF-2 and TGF Beta1 in brain extracellular fluid (CSF) in injury states, and in neurodegenerative diseases associated with aging.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS027601-09
Application #
2750840
Study Section
Neurology A Study Section (NEUA)
Program Officer
Spinella, Giovanna M
Project Start
1989-08-01
Project End
1999-07-31
Budget Start
1998-08-01
Budget End
1999-07-31
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Rhode Island Hospital (Providence, RI)
Department
Type
DUNS #
161202122
City
Providence
State
RI
Country
United States
Zip Code
02903
Sharma, Hari Shanker; Zimmermann-Meinzingen, Sibilla; Johanson, Conrad E (2010) Cerebrolysin reduces blood-cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat. Ann N Y Acad Sci 1199:125-37
Zipser, B D; Johanson, C E; Gonzalez, L et al. (2007) Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging 28:977-86
Chan, Charles; Moore, Brian E; Cotman, Carl W et al. (2006) Musashi1 antigen expression in human fetal germinal matrix development. Exp Neurol 201:515-8
Sharma, H S; Duncan, J A; Johanson, C E (2006) Whole-body hyperthermia in the rat disrupts the blood-cerebrospinal fluid barrier and induces brain edema. Acta Neurochir Suppl 96:426-31
Johanson, C E; Donahue, J E; Spangenberger, A et al. (2006) Atrial natriuretic peptide: its putative role in modulating the choroid plexus-CSF system for intracranial pressure regulation. Acta Neurochir Suppl 96:451-6
Johanson, Conrad E; Duncan, John A; Stopa, Edward G et al. (2005) Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route. Pharm Res 22:1011-37
Smith, David E; Johanson, Conrad E; Keep, Richard F (2004) Peptide and peptide analog transport systems at the blood-CSF barrier. Adv Drug Deliv Rev 56:1765-91
Preston, J E; McMillan, P N; Stopa, E G et al. (2003) Atrial natriuretic peptide induction of dark epithelial cells in choroid plexus: consistency with the model of CSF downregulation in hydrocephalus. Eur J Pediatr Surg 13 Suppl 1:S40-2
Anthony, Shawn G; Schipper, Hyman M; Tavares, Rosemarie et al. (2003) Stress protein expression in the Alzheimer-diseased choroid plexus. J Alzheimers Dis 5:171-7
Szmydynger-Chodobska, Joanna; Chun, Zachary G; Johanson, Conrad E et al. (2002) Distribution of fibroblast growth factor receptors and their co-localization with vasopressin in the choroid plexus epithelium. Neuroreport 13:257-9

Showing the most recent 10 out of 46 publications